We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
THC Q3 Earnings Call Highlights Higher Outlook and Margin Gains
Read MoreHide Full Article
Key Takeaways
Tenet's Q3 adjusted EPS surged 79.5% to $6.64, while net operating revenues rose 6.5% to $5.63B.
THC raises 2026 adjusted EBITDA guidance to $5.05-$5.20B, aided by $147M in Q3 Conifer transition benefits.
Tenet's hospital adjusted admissions rose 3.2%, while USPI's EBITDA climbed 9.1% on higher-acuity care.
Tenet Healthcare Corporation (THC - Free Report) emphasized operational efficiency, higher-acuity services and ambulatory expansion during its third-quarter 2026 earnings call. Management raised its full-year outlook, supported by strong underlying performance and benefits from contract transition activities.
Executives also addressed declining health insurance exchange enrollment, reimbursement uncertainty and opportunities to improve hospital productivity. The discussion highlighted Tenet's focus on sustaining profitability while expanding its surgical care network.
THC Q3 Earnings Beat Estimates on Revenue Growth
Tenet reported third-quarter adjusted earnings of $6.64 per share, surpassing the Zacks Consensus Estimate of $4.6. Earnings increased 79.5% year over year from $3.7 per share.
Net operating revenues increased 6.5% to $5.63 billion, exceeding the Zacks Consensus Estimate of $5.47 billion. GAAP earnings rose to $12.41 per share from $3.86 a year earlier.
Tenet Healthcare Corporation Price, Consensus and EPS Surprise
Consolidated adjusted EBITDA increased 23.3% to $1.36 billion, with margin expanding 330 basis points to 24.1%. Results included a $147 million favorable benefit from Conifer contract transition activities.
Tenet Raises Outlook but Flags 2027 Adjustments
Chairman and chief executive officer Saum Sutaria raised full-year adjusted EBITDA guidance to $5.05-$5.2 billion, representing a $195 million increase at the midpoint.
Chief financial officer Sun Park projected 2026 revenues of $22.05-$22.45 billion and adjusted earnings of $22.05-$23.01 per share. Adjusted free cash flow guidance increased to $2.825-$3.125 billion.
Sutaria expects adjusted EBITDA growth in 2027 after excluding $450 million of nonrecurring Conifer transition benefits recognized in 2026. Management continues assessing exchange enrollment and Medicaid policy risks.
THC Ambulatory Growth Benefits From Higher-Acuity Care
United Surgical Partners International (USPI) generated adjusted EBITDA of $537 million, increasing 9.1% year over year.
Same-facility revenues increased 4.5%, supported by 6.1% higher revenue per case, despite a 1.5% decline in surgical case volumes. Total joint replacements increased 12.8%.
Responding to Deutsche Bank, Sutaria identified orthopedics, urology, spine and advanced robotics as important growth opportunities. Management continues pursuing acquisitions, partnerships and new surgical centers.
Park highlighted sustained expense management and technology-enabled productivity improvements. Exchange admissions and revenues declined 18%, creating an unfavorable payer mix.
During questioning from Guggenheim, Park emphasized favorable commercial contract renewals, generally ranging from 3% to 5%. More than 90% of next year's commercial contracts were already secured.
THC Addresses Conifer's Nonrecurring Benefits
The accelerated transition of CommonSpirit revenue cycle management services contributed $147 million to third-quarter adjusted EBITDA.
Park explained that $97 million reflected revenue recognition timing, while approximately $50 million came from transition-related efficiencies.
Responding to Leerink Partners, Park clarified that the timing benefit shifted revenue from the fourth quarter into the third. Management expects the broader $450 million transition contribution to create a comparison headwind in 2027.
Tenet Prioritizes Cash Flow and Shareholder Returns
Tenet generated $1.10 billion in third-quarter adjusted free cash flow, bringing year-to-date adjusted free cash flow to $2.52 billion.
Management repurchased $1.615 billion of shares during the first nine months. Net debt to adjusted EBITDA declined to 2.11 times.
Park identified ambulatory acquisitions, hospital investments, share repurchases and debt management as capital allocation priorities. Management emphasized maintaining financial flexibility alongside growth investments.
THC Maintains Focus on Sustainable Operations
Management's overarching message emphasized operating discipline, higher-acuity services and continued expansion of the ambulatory platform.
Sutaria expressed confidence in Tenet's underlying growth prospects while acknowledging reimbursement uncertainty and the need to offset nonrecurring benefits when assessing 2027 performance.
The stock holds a Value, Momentum and VGM Score of A, alongside a Growth Score of B. These favorable Style Scores reflect attractive characteristics across valuation, growth and momentum measures.
However, the Zacks Rank #3 provides a more balanced signal than the top-ranked stocks typically favored by the combined Zacks framework. The Rank can change as analysts revise earnings estimates following the latest quarterly results.
View the Zacks #1 Rank List
Image: Bigstock
THC Q3 Earnings Call Highlights Higher Outlook and Margin Gains
Key Takeaways
Tenet Healthcare Corporation (THC - Free Report) emphasized operational efficiency, higher-acuity services and ambulatory expansion during its third-quarter 2026 earnings call. Management raised its full-year outlook, supported by strong underlying performance and benefits from contract transition activities.
Executives also addressed declining health insurance exchange enrollment, reimbursement uncertainty and opportunities to improve hospital productivity. The discussion highlighted Tenet's focus on sustaining profitability while expanding its surgical care network.
THC Q3 Earnings Beat Estimates on Revenue Growth
Tenet reported third-quarter adjusted earnings of $6.64 per share, surpassing the Zacks Consensus Estimate of $4.6. Earnings increased 79.5% year over year from $3.7 per share.
Net operating revenues increased 6.5% to $5.63 billion, exceeding the Zacks Consensus Estimate of $5.47 billion. GAAP earnings rose to $12.41 per share from $3.86 a year earlier.
Tenet Healthcare Corporation Price, Consensus and EPS Surprise
Tenet Healthcare Corporation price-consensus-eps-surprise-chart | Tenet Healthcare Corporation Quote
Consolidated adjusted EBITDA increased 23.3% to $1.36 billion, with margin expanding 330 basis points to 24.1%. Results included a $147 million favorable benefit from Conifer contract transition activities.
Tenet Raises Outlook but Flags 2027 Adjustments
Chairman and chief executive officer Saum Sutaria raised full-year adjusted EBITDA guidance to $5.05-$5.2 billion, representing a $195 million increase at the midpoint.
Chief financial officer Sun Park projected 2026 revenues of $22.05-$22.45 billion and adjusted earnings of $22.05-$23.01 per share. Adjusted free cash flow guidance increased to $2.825-$3.125 billion.
Sutaria expects adjusted EBITDA growth in 2027 after excluding $450 million of nonrecurring Conifer transition benefits recognized in 2026. Management continues assessing exchange enrollment and Medicaid policy risks.
THC Ambulatory Growth Benefits From Higher-Acuity Care
United Surgical Partners International (USPI) generated adjusted EBITDA of $537 million, increasing 9.1% year over year.
Same-facility revenues increased 4.5%, supported by 6.1% higher revenue per case, despite a 1.5% decline in surgical case volumes. Total joint replacements increased 12.8%.
Responding to Deutsche Bank, Sutaria identified orthopedics, urology, spine and advanced robotics as important growth opportunities. Management continues pursuing acquisitions, partnerships and new surgical centers.
Tenet Hospital Margins Improve Despite Payer Pressure
Hospital adjusted admissions increased 3.2%, while segment adjusted EBITDA reached $818 million.
Park highlighted sustained expense management and technology-enabled productivity improvements. Exchange admissions and revenues declined 18%, creating an unfavorable payer mix.
During questioning from Guggenheim, Park emphasized favorable commercial contract renewals, generally ranging from 3% to 5%. More than 90% of next year's commercial contracts were already secured.
THC Addresses Conifer's Nonrecurring Benefits
The accelerated transition of CommonSpirit revenue cycle management services contributed $147 million to third-quarter adjusted EBITDA.
Park explained that $97 million reflected revenue recognition timing, while approximately $50 million came from transition-related efficiencies.
Responding to Leerink Partners, Park clarified that the timing benefit shifted revenue from the fourth quarter into the third. Management expects the broader $450 million transition contribution to create a comparison headwind in 2027.
Tenet Prioritizes Cash Flow and Shareholder Returns
Tenet generated $1.10 billion in third-quarter adjusted free cash flow, bringing year-to-date adjusted free cash flow to $2.52 billion.
Management repurchased $1.615 billion of shares during the first nine months. Net debt to adjusted EBITDA declined to 2.11 times.
Park identified ambulatory acquisitions, hospital investments, share repurchases and debt management as capital allocation priorities. Management emphasized maintaining financial flexibility alongside growth investments.
THC Maintains Focus on Sustainable Operations
Management's overarching message emphasized operating discipline, higher-acuity services and continued expansion of the ambulatory platform.
Sutaria expressed confidence in Tenet's underlying growth prospects while acknowledging reimbursement uncertainty and the need to offset nonrecurring benefits when assessing 2027 performance.
What Zacks Rank and Style Scores Indicate for THC
THC currently carries a Zacks Rank #3 (Hold), indicating a neutral near-term earnings estimate revision outlook under the Zacks framework. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The stock holds a Value, Momentum and VGM Score of A, alongside a Growth Score of B. These favorable Style Scores reflect attractive characteristics across valuation, growth and momentum measures.
However, the Zacks Rank #3 provides a more balanced signal than the top-ranked stocks typically favored by the combined Zacks framework. The Rank can change as analysts revise earnings estimates following the latest quarterly results.